High-resolution HLA typing identifies a new 'super responder' subgroup of HLA-C*06:02-positive psoriatic patients: HLA-C*06:02/HLA-C*04, in response to ustekinumab

J Eur Acad Dermatol Venereol. 2019 Oct;33(10):e364-e367. doi: 10.1111/jdv.15659. Epub 2019 May 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Alleles
  • Dermatologic Agents / therapeutic use*
  • Female
  • HLA-C Antigens / genetics*
  • HLA-C Antigens / immunology
  • Histocompatibility Testing*
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / immunology
  • Ustekinumab / therapeutic use*

Substances

  • Dermatologic Agents
  • HLA-C Antigens
  • Ustekinumab